Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels
2011

Genetic Factors Influencing vWF and FVIII Plasma Levels

Sample size: 1624 publication Evidence: moderate

Author Information

Author(s): Antoni Guillemette, Tiphaine Oudot-Mellakh, Apostolos Dimitromanolakis, Marine Germain, William Cohen, Philip Wells, Mark Lathrop, France Gagnon, Pierre-Emmanuel Morange, David-Alexandre Tregouet

Primary Institution: UMR_S 937, INSERM, Paris, France

Hypothesis

The study aims to identify novel single nucleotide polymorphisms (SNPs) that could influence the variability of vWF and FVIII plasma levels.

Conclusion

The study has generated new knowledge on genomic regions deserving further investigations in the search for genetic factors influencing vWF and FVIII plasma levels.

Supporting Evidence

  • Ten SNPs were associated with plasma vWF levels at p < 10-5.
  • Six SNPs were specifically associated with FVIII levels.
  • Previously reported associations with vWF and FVIII levels were replicated.

Takeaway

Researchers looked at the genes that affect two important blood factors, vWF and FVIII, to find out why some people have higher levels, which can lead to health problems.

Methodology

The study combined results from three independent genome-wide association studies (GWAS) involving a total of 1,624 subjects to identify SNPs associated with vWF and FVIII levels.

Limitations

No SNP reached the genome-wide significance level, suggesting that additional common SNPs influencing vWF and FVIII levels may explain less than 2% of the variability.

Participant Demographics

Most participants were of French origin, with a mix of unrelated individuals and extended families ascertained through probands with idiopathic venous thrombosis.

Statistical Information

P-Value

P = 0.0056

Statistical Significance

p<10-5

Digital Object Identifier (DOI)

10.1186/1471-2350-12-102

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication